Press ReleaseSource: Genesis Worldwide Inc.

Genesis Worldwide Inc. Announces Third Quarter Fiscal 2008 Results
Thursday November 6, 2008 2:00 am ET

Licensing Division Achieves Sequential Operating Profitability and Signs Fourth License in Fiscal 2008 for the Baltic Market

MISSISSAUGA, ONTARIO--(MARKET WIRE)--Nov 6, 2008 -- Genesis Worldwide Inc. ("Genesis" or the "Company"), (Toronto:GWI.TO - News)(AIM: GWI), a leading provider of 'green' building technology, announces its financial results for the third quarter ended September 30, 2008. The Company reports its financial statements in accordance with Canadian generally accepted accounting principles ("GAAP") and reports in Canadian dollars.

Three Months Ended September 30, 2008

 

- Total revenue for the third quarter ended September 30, 2008 deceased
  24.7% to $5,301,563, compared to $7,037,823 for the third quarter of 2007.

- Operating expenses, excluding severance, for the third quarter ended
  September 30, 2008 decreased 16.6% to $2,679,749, compared to $3,214,409
  for the second quarter of 2008.

- Revenue for the licensing division for the third quarter ended
  September 30, 2008 decreased 15.2% to $2,746,520, compared to $3,239,065
  for the same period in 2007. Comparative quarterly results will vary for
  this division depending primarily on the timing of shipments of its
  industrial products.

- Revenue for the structural products division for the third quarter ended
  September 30, 2008 decreased 32.7% to $2,555,043, compared to $3,798,758
  recorded in the third quarter of 2007.

- Total contribution margin decreased by 32.5% in the third quarter ended
  September 30, 2008 to $1,677,391, compared to $2,486,840 for the same
  quarter last year.

- Net loss for the third quarter ended September 30, 2008 increased to
  $1,906,844, or ($0.06) per common share, compared to a net loss of
  $872,748, or ($0.03) per common share for the third quarter of 2007.

- The cash balance for the three months ended September 30, 2008 was
  $706,056.

- The Company continues to look at other options/alternatives to add
  additional capital in the form of debt or new capital, which would allow
  the Company to advance its growth initiatives.

Three Months Ended September 30, 2008
-------------------------------------
                                               Structural
(unaudited, in thousands of dollars) Licensing   Products Corporate   Total
---------------------------------------------------------------------------
Revenue                                $ 2,746    $ 2,555     $ --  $ 5,301
Contribution margin                      1,343        324       --    1,667
Operating expenses                      (1,039)    (1,019)  (1,086)  (3,144)
Income/(loss) before other expenses        304       (695)  (1,086)  (1,477)
Other income/(expenses)                   (165)      (279)      14     (430)
Net income/(loss) for the quarter          139       (974)  (1,072)  (1,907)
----------------------------------------------------------------------------
----------------------------------------------------------------------------

Financial Highlights

Nine Months Ended September 30, 2008

 

- Total revenue for the nine months ended September 30, 2008 increased 4.8%
  to $16,809,744, compared to $16,045,385 for the same period in 2007.

- Revenue for the licensing division for the nine months ended September 30,
  2008 increased 6.3% to $7,311,009, compared to $6,875,689 for the same
  period in 2007.

- Revenue for the structural products division for the nine months ended
  September 30, 2008 increased 3.6% to $9,498,735, compared to $9,169,696
  for the first nine months of 2007.

- Total contribution margin for the nine months ended September 30, 2008
  decreased 4.5% to $5,117,860, compared to $5,358,983 recorded in the same
  period in 2007. Contribution margin, excluding costs associated with
  defective products and services received from third parties, would have
  increased to $5,947,860, an increase of 11.0%, compared to $5,358,983
  recorded in the same period in 2007.

- Net loss for the nine months ended September 30, 2008 was $5,535,989, or
  ($0.18) per common share, compared to a net loss of $4,698,695, or ($0.19)
  per common share, for the same period in 2007.

Nine Months Ended September 30, 2008
------------------------------------
                                              Structural
(unaudited, in thousands of dollars) Licensing  Products  Corporate   Total
---------------------------------------------------------------------------
Revenue                                $ 7,311   $ 9,499       $ -- $16,810
Contribution margin                      4,087     1,031         --   5,118
Operating expenses                      (3,945    (3,147)    (2,453) (9,545)
Income/(loss) before other expenses        142    (2,116)    (2,453) (4,427)
Other income/(expenses)                   (481)     (688)        60  (1,109)
Net loss for the period                   (339)   (2,804)    (2,393) (5,536)
----------------------------------------------------------------------------
----------------------------------------------------------------------------

Contracted Backlog

Contracted backlog for the licensing division is defined as undelivered contractual commitments, other than minimum royalty obligations, and assumes that in cases of multi-year/multi-facility commitments by licensees, subsequent facilities match the industrial technology configured for the first facility. Contracted backlog for the structural products division is defined as the undelivered portion of signed construction contracts. The timing of these contractual commitments into revenue is uncertain and the possibility exists that contractual commitments can be de-booked.

A breakdown of the Company's contracted backlog is as follows:

 

- Total backlog as at September 30, 2008 was approximately $49,000,000,
  representing a 48% increase over backlog of approximately $33,000,000
  as at September 30, 2007.

- Backlog for the licensing division as at September 30, 2008 was
  approximately $20,000,000. This excludes minimum royalty obligations.

- Backlog for the structural products division as at September 30, 2008 was
  approximately $29,000,000.

Business Update

Licensing Division

 

- Achieved operating profitability (income before other expenses) of
  $304,000, and net income of $139,000 for the third quarter of fiscal 2008;

- Operating expenses, excluding corporate reorganization costs, decreased by
  19% as a result of cost cutting initiatives;

- Signed its fourth license agreement in 2008 with UAB Baltic Light Steel
  Framing, targeting the Baltic region, which includes Lithuania, Latvia and
  Estonia. The Company achieved its 2008 goal of attaining four licensees
  one quarter ahead of target. The Company's Ireland office was successful
  in securing this transaction;

- Backlog increased to $20,000,000, compared to $4,000,000 for the third
  quarter of 2007;

- Completed the development, testing and manufacturing of its newest
  Material Optimization Technology ("MOT") series, MOT 6000, for its central
  Russia licensee, Greenford Trading, which was shipped in July 2008; and

- Expanded its process patent filings for its Coil-to-Panel ("CTP")
  manufacturing line to markets in Dubai, Turkey, Russia, Ukraine, China,
  India, Australia, and the European Union.

Structural Products Division

 

- Commenced on-site installation of four new projects;

- Signed contracts for new vertical building markets to provide light steel
  framing to schools, portable buildings, and government assisted-living
  affordable housing;

- the Genesis Solution can now be applied to structures eight storeys and
  under, an increase of two storeys;

- Completed remedial work relating to defective products and services
  provided by third party vendors in the previous quarter, incurring total
  costs of $300,000 for the quarter.

- Expanded utilization of its MOT to produce roof solutions;

- Backlog was $29,000,000, which was consistent with the third quarter of
  2007; and

- Operating expenses decreased by 13% as a result of cost cutting
  initiatives.

Corporate Division

- Announced the appointment of its new Chief Financial Officer, Greg Kent.

"During the third quarter of 2008, the Company's licensing division, GenesisTP Inc., signed a new license agreement for the Baltic region. This brings the total number of new license agreements for the 2008 fiscal period to four, achieving the Company's fiscal year 2008 target one quarter early," stated Vince Mifsud, Genesis' President and Chief Executive Officer. "We are also pleased to report that this division achieved operating profit in the quarter."

Mr. Mifsud continued, "The Company's structural products division, KML Building Solutions, continued to enter new vertical building markets, such as schools, portable buildings, and government assisted-living affordable housing. During the quarter, this division completed the remedial work incurred as a result of what the Company believes were defective products and services provided by third party vendors. With these costs behind us, the deployment of MOT and a strong backlog, we believe that this division has a clear road map to achieving operating profits."

Further information regarding the Company, and its business and operations, may be obtained from the Company's continuous disclosure documents filed from time-to-time with the Canadian securities regulatory authorities. These continuous disclosure documents are available through the Company's web site at www.genesisworldwide.com or through the SEDAR website maintained by the Canadian securities regulatory authorities, which can be accessed at www.sedar.com.

Conference Call

The Genesis management team will discuss its third quarter 2008 financial results on a conference call to be held on Thursday, November 6, 2008 at 8:30 a.m. Eastern time (1:30 p.m. BST). There will be a short presentation followed by a question and answer period lasting for approximately one (1) hour.

Conference Call Details

 

    Date:    Thursday, November 6, 2008
    Time:    8:30 a.m. Eastern time (1:30 p.m. BST)
    Local dial-in: 416-641-6123
    North America toll-free:  866-300-7687
    Global toll-free: 800-6578-9898 (dial the international access code of
    the country you are calling from, i.e. a call from the United Kingdom
    would be dialed 00-800-6578-9898)

A replay of the call will be available by dialing 416-695-5800 (local callers only), or toll-free at 1-800-408-3053 (passcode 3274156#), from approximately 12:00 p.m. Eastern time on the date of the call through to Thursday, November 13, 2008.

About Genesis Worldwide Inc.

Genesis develops and licenses 'green' building technology. Genesis offers licensees a turn-key solution which includes software applications, industrial technologies, and a wide range of services. The Genesis Solution encompasses engineered processes and materials that are environmentally sustainable or 'green'. Genesis is headquartered in Mississauga, Ontario, Canada, and has licensees in the United States, Canada, Europe and the Middle East. For additional information about the Company, visit www.genesisworldwide.com.

Caution Regarding Forward Looking Information

Certain statements in this press release which are not historical facts constitute forward-looking statements or forward-looking information within the meaning of applicable securities laws ("forward-looking statements") and are made pursuant to the "safe harbour" provisions of such laws. Statements related to the Company's projected revenues, earnings, growth rates, performance, business prospects and opportunities are forward-looking statements, as are any statements relating to future events, conditions or circumstances. The use of terms such as "may", "will", "should", "plan", "believes", "predict", "potential" "anticipate", "expect", "project", "target", "estimate", "continue" and similar terms are intended to assist in identification of these forward-looking statements. These statements are based on certain factors and assumptions including expected growth, results of operations, performance and business prospects and opportunities. These assumptions, although considered reasonable by the Company at the time of preparation, may prove to be incorrect.

Readers are cautioned not to place undue reliance upon any such forward-looking statements. Such forward-looking statements are not promises or guarantees of future performance and involve both known and unknown risks and uncertainties that may cause the actual results, performance or achievements of the Company to differ materially from the results, performance, achievements or developments expressed or implied by such forward-looking statements.

Many factors could cause the actual results of the Company to differ materially from the results, performance, achievements or developments expressed or implied by such forward-looking statements, including, without limitation, those factors discussed under the heading "Risk Factors" in the Company's most recent Annual Information Form ("AIF"), a copy of which is available on SEDAR at www.sedar.com. Forward-looking statements are based on management's current plans, estimates, projections, beliefs and opinions, and the Company does not undertake any obligation to update forward-looking statements should assumptions related to these plans, estimates, projections, beliefs and opinions change.

 

                           Genesis Worldwide Inc.

                    Interim Consolidated Balance Sheets
                                (unaudited)

                                                     As at           As at
                                              September 30     December 31
                                                      2008            2007
                                                         $               $
                                              -----------------------------
ASSETS
Current
Cash and cash equivalents                          706,056       5,987,862
Accounts receivable                              7,743,224      11,347,550
Inventories and deposits on inventory              689,306         895,686
Prepaid expenses                                   521,304         342,516
                                              -----------------------------
Total current assets                             9,659,890      18,573,614
Restricted cash                                    500,000              --
Long-term accounts receivable                      431,250         287,500
Property, plant and equipment                    5,153,359       4,530,567
Patent deferred costs                              248,739         192,969
Intangible asset                                 1,848,310       2,050,548
                                              -----------------------------
                                                17,841,548      25,635,198
                                              -----------------------------
                                              -----------------------------

LIABILITIES AND SHAREHOLDERS' EQUITY
Current
Accounts payable and accrued liabilities         6,242,214       7,566,970
Deferred revenue - current portion               1,639,040       4,459,648
Term loan - current portion                        559,561              --
Minimum royalty payment obligations                355,511         173,330
                                              -----------------------------
Total current liabilities                        8,796,326      12,199,948
                                              -----------------------------

Long-term
Deferred revenue                                   431,250         287,500
Term loan                                        1,151,952              --
Minimum royalty payment obligations              1,105,123       1,377,869
                                              -----------------------------
Total long-term liabilities                      2,688,325       1,665,369
                                              -----------------------------
                                              -----------------------------

Shareholders' equity
Capital stock                                   56,733,075      56,733,075
Contributed surplus                              1,201,479       1,078,474
Deficit                                        (51,577,657)    (46,041,668)
                                              -----------------------------
Total shareholders' equity                       6,356,897      11,769,881
                                              -----------------------------
                                                17,841,548      25,635,198
                                              -----------------------------
                                              -----------------------------



                           Genesis Worldwide Inc.

                Interim Consolidated Statements of Loss and
                       Comprehensive Loss and Deficit
                                (unaudited)

                              Three months ended         Nine months ended
                        ---------------------------------------------------
                          September    September    September    September
                            30 2008      30 2007      30 2008      30 2007
                                  $            $            $            $
                        ---------------------------------------------------

Revenues
Licensing                 2,746,520    3,239,065    7,311,009    6,875,689
Structural products       2,555,043    3,798,758    9,498,735    9,169,696
                        ---------------------------------------------------
Total revenues            5,301,563    7,037,823   16,809,744   16,045,385
                        ---------------------------------------------------

Direct cost of revenues
Licensing                 1,402,877    1,446,692    3,223,480    3,526,635
Structural products       2,231,295    3,104,291    8,468,404    7,159,767
                        ---------------------------------------------------
Total direct cost of
 revenues                 3,634,172    4,550,983   11,691,884   10,686,402
                        ---------------------------------------------------
                          1,667,391    2,486,840    5,117,860    5,358,983
                        ---------------------------------------------------

Expenses
Research and development    278,665      264,249    1,005,939      793,538
SR&ED investment tax
 credits                    (91,534)          --     (165,025)    (418,161)
Selling and marketing       678,784      501,862    1,982,541    1,327,786
Engineering and project
 management                 323,831      455,701    1,343,015    1,313,499
General and
 administrative           1,138,259    1,422,218    3,826,673    3,249,935
Occupancy                   351,744      442,538    1,087,159    1,070,078
Corporate
 reorganization costs       464,448           --      464,448           --
Plant commissioning and
 restructuring costs             --       27,121           --      776,418
                        ---------------------------------------------------
                          3,144,197    3,113,689    9,544,750    8,113,093
                        ---------------------------------------------------
Loss before other
 expenses                (1,476,806)    (626,849)  (4,426,890)  (2,754,110)
                        ---------------------------------------------------
Amortization of
 property, plant and
 equipment                  220,763      133,030      657,101      509,091
Amortization of
 intangible asset            67,413       67,413      202,238      202,238
Foreign exchange loss
 (gain)                     (33,732)      36,289      (21,520)     (13,331)
Interest (income)
 /expense                    67,560      (99,954)      15,778      (99,954)
Minimum royalty
 accretion                   71,966       74,804      219,434      223,276
Debenture and loan
 interest expense            36,068       34,317       36,068    1,123,265
                        ---------------------------------------------------
                            430,038      245,899    1,109,099    1,944,585
                        ---------------------------------------------------
Net loss and
 comprehensive loss for
 the period              (1,906,844)    (872,748)  (5,535,989)  (4,698,695)

Deficit, beginning of
 period                 (49,670,813) (45,359,753) (46,041,668) (41,533,806)
                        ---------------------------------------------------

Deficit, end of period  (51,577,657) (46,232,501) (51,577,657) (46,232,501)
                        ---------------------------------------------------
                        ---------------------------------------------------

Loss per share
Basic and diluted           $ (0.06)     $ (0.03)     $ (0.18)     $ (0.19)
                        ---------------------------------------------------
                        ---------------------------------------------------
Weighted average number
 of shares outstanding   30,982,858   30,765,467   30,982,858   24,279,561
                        ---------------------------------------------------
                        ---------------------------------------------------



                           Genesis Worldwide Inc.

               Interim Consolidated Statements of Cash Flows
                                (unaudited)

                                Three months ended       Nine months ended
                            -----------------------------------------------
                             September   September   September   September
                               30 2008     30 2007     30 2008     30 2007
                                     $           $           $           $
                            -----------------------------------------------
OPERATING ACTIVITIES
Net loss for the period     (1,906,842)   (872,748) (5,535,989) (4,698,695)
Adjustments for non-cash
 items
 Amortization of property,
  plant and equipment
  and intangible asset         288,175     200,443     859,338     711,329
 Stock-based compensation
  expense                       33,005      41,718     123,005     101,781
 Debenture interest expense
  accretion                         --      34,317          --     815,965
 Minimum royalty accretion      71,966      74,804     219,434     223,276
                            -----------------------------------------------
                            (1,513,696)   (521,466) (4,334,212) (2,846,344)

Changes in non-cash working
 capital balances related to
 operations
 Accounts receivable         3,571,603  (4,435,344)  3,604,326  (4,106,453)
 Inventories and deposits on
  inventory                  1,294,395      10,483     (83,184)    (78,376)
 Prepaid expenses               38,815      74,245     110,777    (356,331)
 Accounts payable and
  accrued liabilities         (888,616)  1,097,062  (1,324,756)    687,876
 Deferred revenue           (2,939,831)  2,533,655  (2,820,608)  3,169,517
                            -----------------------------------------------
Cash used in operating
 activities                   (437,330) (1,241,365) (4,847,657) (3,530,111)
                            -----------------------------------------------

FINANCING ACTIVITIES
Debenture proceeds           1,800,000          --   1,800,000   2,000,000
Debenture repayment            (88,487) (6,120,000)    (88,487) (6,120,000)
Restricted cash               (500,000)         --    (500,000)         --
Share issue proceeds (net
 of transaction costs paid)         --  16,343,175          --  16,343,175
                            -----------------------------------------------
Cash provided by financing
 activities                  1,211,513  10,223,175   1,211,513  12,223,175
                            -----------------------------------------------

INVESTING ACTIVITIES
Additions to property,
 plant and equipment           (41,845) (1,505,450) (1,279,892) (2,053,929)
Deferred IPO costs                  --     (68,603)         --     (68,603)
Deferred patent costs          (55,770)         --     (55,770)         --
Minimum royalties paid        (150,000)    (80,000)   (310,000)   (240,000)
                            -----------------------------------------------
Cash used in investing
 activities                   (247,615) (1,654,053) (1,645,662) (2,362,532)
                            -----------------------------------------------

Net increase/(decrease) in
 cash and cash equivalents
 during the period             526,568   7,327,757  (5,281,806)  6,330,532
Cash and cash equivalents,
 beginning of period           179,488      16,161   5,987,862   1,011,386
                            -----------------------------------------------
Cash and cash equivalents,
 end of period                 706,056   7,343,918     706,056   7,341,918
                            -----------------------------------------------
                            -----------------------------------------------

Supplemental cash flow
 information
Interest paid                   36,068      10,479      36,068     323,321
                            -----------------------------------------------
                            -----------------------------------------------


Contact:
     Contacts:
     Genesis Worldwide Inc.
     Catherine Smyth
     Manager, Investor Relations
     (905) 285-9909, ext. 302
     Website: http://www.genesisworldwide.com
      
     Canaccord Adams
     Robert Finlay / L. Warren Pimm
     +44 020 7050 6500
      

Source: Genesis Worldwide Inc.


Mail to Friend Email Story
Alerts Set News Alert
Printer
Version  Print Story 


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Marketwire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.